ATE488498T1 - Verfahren zur herstellung von ace hemmern - Google Patents

Verfahren zur herstellung von ace hemmern

Info

Publication number
ATE488498T1
ATE488498T1 AT04731808T AT04731808T ATE488498T1 AT E488498 T1 ATE488498 T1 AT E488498T1 AT 04731808 T AT04731808 T AT 04731808T AT 04731808 T AT04731808 T AT 04731808T AT E488498 T1 ATE488498 T1 AT E488498T1
Authority
AT
Austria
Prior art keywords
ace inhibitors
amino acid
activated
producing
producing ace
Prior art date
Application number
AT04731808T
Other languages
English (en)
Inventor
Branko Jenko
Original Assignee
Lek Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lek Pharmaceuticals filed Critical Lek Pharmaceuticals
Application granted granted Critical
Publication of ATE488498T1 publication Critical patent/ATE488498T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT04731808T 2003-05-16 2004-05-07 Verfahren zur herstellung von ace hemmern ATE488498T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SI200300123A SI21507A (sl) 2003-05-16 2003-05-16 Postopek za pripravo spojin z ace inhibitornim delovanjem
PCT/SI2004/000021 WO2004101515A1 (en) 2003-05-16 2004-05-07 A process for the preparation of compounds having an ace inhibitory action

Publications (1)

Publication Number Publication Date
ATE488498T1 true ATE488498T1 (de) 2010-12-15

Family

ID=33448812

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04731808T ATE488498T1 (de) 2003-05-16 2004-05-07 Verfahren zur herstellung von ace hemmern

Country Status (7)

Country Link
US (1) US7671215B2 (de)
EP (1) EP1628956B1 (de)
AT (1) ATE488498T1 (de)
DE (1) DE602004030112D1 (de)
RU (1) RU2377236C2 (de)
SI (2) SI21507A (de)
WO (1) WO2004101515A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2468724T3 (en) * 2006-12-21 2016-02-22 Zealand Pharma As Synthesis of pyrrolidine compounds
US20090076126A1 (en) * 2007-09-17 2009-03-19 Protia, Llc Deuterium-enriched enalapril
CN102498098A (zh) 2009-07-16 2012-06-13 艾博特公司 作为群多普利中间体的(2S,3aR,7aS)-八氢-1H-吲哚羧酸的合成方法
EP2906536B1 (de) * 2012-10-10 2018-03-14 Piramal Enterprises Limited Verbessertes verfahren zur herstellung eines perindopril-zwischenprodukts

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE289543C (de) 1913-08-18
FR2620709B1 (fr) * 1987-09-17 1990-09-07 Adir Procede de synthese industrielle du perindopril et de ses principaux intermediaires de synthese
ATE174343T1 (de) * 1991-02-27 1998-12-15 Lacer Sa Antihypertensive n-(alpha-substituiertes pyridyl)-carbonyldipeptide
DE4334936C1 (de) * 1993-10-13 1995-06-22 Karla Dr Lehmann Arzneimittel zur optimierten Behandlung eines erhöhten Blutdrucks und zur Verhütung von Folgeerkrankungen
US5864040A (en) 1996-01-11 1999-01-26 American Home Products Corporation Benzimidazole phosphono-amino acids
RU2119314C1 (ru) * 1996-02-05 1998-09-27 Московский научно-исследовательский институт глазных болезней им.Гельмгольца Способ профилактики и лечения изъязвлений роговицы
GB9710612D0 (en) 1997-05-23 1997-07-16 Glaxo Group Ltd Synthesis of acridine derivatives
FR2771010B1 (fr) * 1997-11-19 2003-08-15 Adir Utilisation d'une combinaison d'un inhibiteur de l'enzyme de conversion de l'angiotensine et d'un diuretique pour le traitement des desordres microcirculatoires
PL358618A1 (pl) 2000-03-31 2004-08-09 Pfizer Products Inc. Nowe pochodne piperazyny
GB2375762B (en) 2001-05-21 2003-10-01 Fermenta Biotech Ltd Stereospecific synthesis of 2-hydroxy-4-phenyl-butyric acid esters
WO2002094857A1 (en) * 2001-05-23 2002-11-28 The Curators Of The University Of Missouri Inverse solid phase synthesis of peptides
AR036187A1 (es) * 2001-07-24 2004-08-18 Adir Un proceso para la preparacion de perindopril, compuestos analogos y sus sales, compuesto intermediario 2,5-dioxo-oxazolidina y proceso para preparar un intermediario
GB0119795D0 (en) 2001-08-14 2001-10-03 Smithkline Beecham Plc Novel process

Also Published As

Publication number Publication date
RU2005139158A (ru) 2007-06-27
WO2004101515A1 (en) 2004-11-25
SI21507A (sl) 2004-12-31
SI1628956T1 (sl) 2011-03-31
EP1628956B1 (de) 2010-11-17
US20070072919A1 (en) 2007-03-29
DE602004030112D1 (de) 2010-12-30
EP1628956A1 (de) 2006-03-01
US7671215B2 (en) 2010-03-02
RU2377236C2 (ru) 2009-12-27

Similar Documents

Publication Publication Date Title
EP2123636A4 (de) Verfahren zur herstellung eines aminoacetylpyrrolidincarbonitrilderivats
ATE475655T1 (de) Verfahren zur herstellung von (s)-4- fluormethyldihydrofuran-2-on
DE50310614D1 (de) Verfahren zur herstellung von c13-alkoholgemischen
ATE366725T1 (de) Verfahren zur herstellung von gereinigten 1,3- substituierten imidazoliumsalzen
DE60321625D1 (de) Verfahren zur Herstellung von Acrylsäure
DE60321626D1 (de) Verfahren zur Herstellung von Acrylsäure
DE602006021411D1 (de) Verfahren zur herstellung von optional 2-substituierten 1,6-dihydro-6-oxo-4-pyrimidincarboxylsäuren
ATE488498T1 (de) Verfahren zur herstellung von ace hemmern
ATE515496T1 (de) Verfahren zur herstellung von enantiomerenangereicherter indolin-2-carbonsäure
ATE441627T1 (de) Verfahren zur herstellung von valsartan
ATE386734T1 (de) Verfahren zur herstellung von (4-hydroxy-6-oxo- tetrahydropyran-2-yl) acetonitril und dessen derivaten
ATE447567T1 (de) Verfahren zur herstellung von tryptase- inhibitoren
ATE451452T1 (de) Verfahren zur enzymatischen reduktion von alkinderivaten
ATE555093T1 (de) Verfahren zur herstellung einer (s)-1-alkyl-2i,6i-pipecoloxylididverbindung
DE602004014822D1 (de) Neues verfahren zur herstellung von nitrooxyderivaten von paracetamol
ATE549315T1 (de) Verfahren zur herstellung von kristallinem perindopril
ATE282589T1 (de) Verfahren zur herstellung eines chiralen-beta- aminosäureesters
ATE466010T1 (de) Verfahren zur herstellung von candesartan
ATE417826T1 (de) Verfahren zur herstellung von zwischenprodukten
DE602005024809D1 (de) Verfahren zur herstellung von gabapentin
DE602004008486D1 (de) Verfahren zur herstellung von (1s,4r)-cis-4-ä2-amino-6-chlor-9h-purin-9-ylü-2-cyclopenten-1-methanol
ATE423096T1 (de) Verfahren zur herstellung von 2- azabicycloä3.3.0üoctan-3-carbonsäurederivaten
EP1420029A3 (de) Verfahren für die Synthese von Perindopril und seiner pharmazeutisch annehmbaren Salzen
ATE496882T1 (de) Verfahren zur herstellung von hochreinem (meth)acryloyloxyalkylisocyanat
ATE533758T1 (de) Verfahren zur herstellung von enantiomerenreinem esomeprazol

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties